Microbe-binding molecules and uses thereof
US-10435457-B2 · Oct 8, 2019 · US
US11400138B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11400138-B2 |
| Application number | US-202017099784-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 17, 2020 |
| Priority date | Aug 6, 2020 |
| Publication date | Aug 2, 2022 |
| Grant date | Aug 2, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for improving a skin condition of a subject in need thereof includes administering to the subject a composition including a bioactive compound. The bioactive compound is a peptide, and includes at least one amino acid sequence as set forth in SEQ ID NO: 1 to SEQ ID NO: 11. Each of the amino acid sequence is a peptide of fish skin.
Opening claim text (preview).
What is claimed is: 1. A method for improving a skin condition of a subject in need thereof comprising administering to the subject a composition comprising a bioactive compound, wherein the bioactive compound is a peptide, the peptide comprises at least one full-length sequence selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 11, each of the full-length sequence is a peptide of fish skin; and the improvement of skin condition comprises reducing wrinkles. 2. The method according to claim 1 , wherein the improvement of skin condition further comorises promoting generation and improving density of skin collagen; the peptide is capable of regulating at least one gene of human fibroblast fibrillin-1 (FBN1) and type IV collagen alpha 1 chain (COL4A1); and the peptide for regulating FBN1 comprises at least one full-length sequence selected from the group consisting of SEQ ID NO: 2 to SEQ ID NO: 11. 3. The method according to claim 1 , wherein the improvement of skin condition further comprises preventing loss of skin collagen; wherein the peptide is capable of regulating at least one gene of tissue inhibitor of metalloproteinases 1 (TIMP1) and matrix metalloproteinase-2 (MMP2); the peptide for regulating TIMP1 comprises at least one full-length sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 11; and the peptide for regulating MMP2 comprises at least one full-length sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 5 and SEQ ID NO: 10. 4. The method according to claim 1 , wherein the improvement of skin condition further comprises reducing loss of skin moisture; and the peptide is capable of regulating an hyaluronan synthase 2 (HAS2) gene. 5. The method according to claim 1 , wherein the improvement of skin condition further comprises improving skin elasticity; the peptide is capable of regulating at least one gene of FBN1, lysyl oxidase (LOX) and elastin (ELN); and the peptide for regulating LOX comprises at least one full-length sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 5, SEQ ID NO: 9 and SEQ ID NO: 11. 6. The method according to claim 1 , wherein the fish skin is a tilapia skin. 7. The method according to claim 1 , wherein a source of the peptide of the fish skin comprises fish skin cells, fish skin collagen or fish muscle cells.
from fish · CPC title
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG] · CPC title
Collagen; Gelatin; Keratin; Derivatives or degradation products thereof · CPC title
Anti-ageing preparations · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.